Wall LR, Ward EC, Cartmill B, et al. - As dysphagia in patients with oropharyngeal (OP) SCC could be mitigated with intensive prophylactic swallowing therapy, researchers examined three service models delivering prophylactic swallowing therapy during (chemo)radiotherapy ([C]RT) for their clinical efficacy. Randomization of patients (n = 79) with OPSCC receiving (C)RT was done: (a) clinician-directed face-to-face therapy (n = 26); (b) telepractice therapy via “SwallowIT” (n = 26); or (c) patient self-directed therapy (n = 27). Outcomes revealed achievement of clinically equivalent outcomes with SwallowIT and traditional service models. Patients preferred SwallowIT and clinician-directed therapy, possibly due to higher levels of therapy support.